131 related articles for article (PubMed ID: 2349580)
21. Two phospholipase A2 inhibitors from the plasma of Cerrophidion (Bothrops) godmani which selectively inhibit two different group-II phospholipase A2 myotoxins from its own venom: isolation, molecular cloning and biological properties.
Lizano S; Angulo Y; Lomonte B; Fox JW; Lambeau G; Lazdunski M; Gutiérrez JM
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):631-9. PubMed ID: 10698689
[TBL] [Abstract][Full Text] [Related]
22. Cross-neutralization of thrombin-like enzymes in snake venoms by polyvalent antivenoms.
Claus I; Mebs D
Toxicon; 1989; 27(12):1397-9. PubMed ID: 2629180
[TBL] [Abstract][Full Text] [Related]
23. The effect of myotoxins isolated from Bothrops snake venoms on multilamellar liposomes: relationship to phospholipase A2, anticoagulant and myotoxic activities.
Díaz C; Gutiérrez JM; Lomonte B; Gené JA
Biochim Biophys Acta; 1991 Dec; 1070(2):455-60. PubMed ID: 1764457
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the myotoxic activity of Bothrops asper myotoxin II in mice by immunization with its synthetic 13-mer peptide 115-129.
Calderón L; Lomonte B
Toxicon; 1999 Apr; 37(4):683-7. PubMed ID: 10082167
[TBL] [Abstract][Full Text] [Related]
25. Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A2 from Bothrops asper snake venom--synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region.
Páramo L; Lomonte B; Pizarro-Cerdá J; Bengoechea JA; Gorvel JP; Moreno E
Eur J Biochem; 1998 Apr; 253(2):452-61. PubMed ID: 9654096
[TBL] [Abstract][Full Text] [Related]
26. Immunochemical properties of the N-terminal helix of myotoxin II, a lysine-49 phospholipase A(2) from Bothrops asper snake venom.
Angulo Y; Núñez CE; Lizano S; Soares AM; Lomonte B
Toxicon; 2001 Jun; 39(6):879-87. PubMed ID: 11137549
[TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of basic myotoxic phospholipases A2 from Bothrops godmani (Godman's pit viper) snake venom.
Díaz C; Gutiérrez JM; Lomonte B
Arch Biochem Biophys; 1992 Oct; 298(1):135-42. PubMed ID: 1524423
[TBL] [Abstract][Full Text] [Related]
28. Alkylation of myotoxic phospholipases A2 in Bothrops moojeni venom: a promising approach to an enhanced antivenom production.
Soares AM; Sestito WP; Marcussi S; Stábeli RG; Andrião-Escarso SH; Cunha OA; Vieira CA; Giglio JR
Int J Biochem Cell Biol; 2004 Feb; 36(2):258-70. PubMed ID: 14643891
[TBL] [Abstract][Full Text] [Related]
29. [(Evaluation of neutralizing ability of four commercially available antivenoms against the venom of Bothrops asper from Costa Rica)].
Bogarín G; Segura E; Durán G; Lomonte B; Rojas G; Gutiérrez JM
Toxicon; 1995 Sep; 33(9):1242-7. PubMed ID: 8585095
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the Myotoxicity Induced by Bothrops jararacussu Venom and Isolated Phospholipases A2 by Specific Camelid Single-Domain Antibody Fragments.
Prado ND; Pereira SS; da Silva MP; Morais MS; Kayano AM; Moreira-Dill LS; Luiz MB; Zanchi FB; Fuly AL; Huacca ME; Fernandes CF; Calderon LA; Zuliani JP; Pereira da Silva LH; Soares AM; Stabeli RG; Fernandes CF
PLoS One; 2016; 11(3):e0151363. PubMed ID: 27028872
[TBL] [Abstract][Full Text] [Related]
31. A new method for the detection of phospholipase A2 variants: identification of isozymes in the venoms of newborn and adult Bothrops asper (terciopelo) snakes.
Moreno E; Alape A; Sánchez M; Gutiérrez JM
Toxicon; 1988; 26(4):363-71. PubMed ID: 3406947
[TBL] [Abstract][Full Text] [Related]
32. Individual expression patterns of myotoxin isoforms in the venom of the snake Bothrops asper.
Lomonte B; Carmona E
Comp Biochem Physiol B; 1992 Jun; 102(2):325-9. PubMed ID: 1617940
[TBL] [Abstract][Full Text] [Related]
33. Effects of a myotoxic phospholipase A2 isolated from Bothrops asper venom on skeletal muscle sarcoplasmic reticulum.
Gutiérrez JM; Rojas G; Lomonte B; Gené JA; Cerdas L
Toxicon; 1987; 25(11):1244-8. PubMed ID: 2963409
[TBL] [Abstract][Full Text] [Related]
34. Production and partial characterization of monoclonal antibodies to Bothrops asper (terciopelo) myotoxin.
Lomonte B; Kahan L
Toxicon; 1988; 26(7):675-89. PubMed ID: 3140427
[TBL] [Abstract][Full Text] [Related]
35. Bothrops fonsecai snake venom activities and cross-reactivity with commercial bothropic venom.
Collaço RC; Randazzo-Moura P; Tamascia ML; da Silva IR; Rocha T; Cogo JC; Hyslop S; Sanny CG; Rodrigues-Simioni L
Comp Biochem Physiol C Toxicol Pharmacol; 2017 Jan; 191():86-100. PubMed ID: 27590117
[TBL] [Abstract][Full Text] [Related]
36. Production of monovalent anti-Bothrops asper antivenom: development of immune response in horses and neutralizing ability.
Gutiérrez JM; Chaves F; Rojas E; Elizondo J; Avila C; Cerdas L
Rev Biol Trop; 1988 Nov; 36(2B):511-7. PubMed ID: 3078800
[TBL] [Abstract][Full Text] [Related]
37. Quantitation by enzyme-immunoassay of antibodies against Bothrops myotoxins in four commercially-available antivenoms.
Lomonte B; Gutiérrez JM; Rojas G; Calderón L
Toxicon; 1991; 29(6):695-702. PubMed ID: 1926170
[TBL] [Abstract][Full Text] [Related]
38. Neutralizing potency of horse antibothropic antivenom. Correlation between in vivo and in vitro methods.
Maria WS; Cambuy MO; Costa JO; Velarde DT; Chávez-Olórtegui C
Toxicon; 1998 Oct; 36(10):1433-9. PubMed ID: 9723841
[TBL] [Abstract][Full Text] [Related]
39. Geographical variability of the venoms of four populations of Bothrops asper from Panama: Toxicological analysis and neutralization by a polyvalent antivenom.
Vélez SM; Salazar M; Acosta de Patiño H; Gómez L; Rodriguez A; Correa D; Saldaña J; Navarro D; Lomonte B; Otero-Patiño R; Gutiérrez JM
Toxicon; 2017 Jun; 132():55-61. PubMed ID: 28392273
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of antivenoms in the neutralization of hyperalgesia and edema induced by Bothrops jararaca and Bothrops asper snake venoms.
Picolo G; Chacur M; Gutiérrez JM; Teixeira CF; Cury Y
Braz J Med Biol Res; 2002 Oct; 35(10):1221-8. PubMed ID: 12424496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
